Table 4 Overall survival of patients after BK-UM administration
From: BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study
Patient no. | Conventional chemotherapy after BK-UM | Overall survival (months) |
|---|---|---|
1 | CDDP + CPT-11 (6 courses) | 28.1 |
2 | – | 3.4 |
3 | CDDP + CPT-11 (6 courses) | 24.3 |
4 | CDDP + CPT-11 (6 courses) | 15.1 |
5 | – | 5.5 |
6 | – | 5.0 |
7 | CDDP + CPT-11 (2 courses) | 7.4 |
8 | CDDP + IFM (2 courses) | 4.2 |
9 | – | 3.6 |
10 | CPT-11 (6 courses) | 14.0 |
11 | CBDCA + Doxil (6 courses) | >60a |